These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 17262699)

  • 1. Immunologic predictors of late cytomegalovirus disease after solid organ transplantation--an elusive goal?
    Boeckh M; Riddell SR
    J Infect Dis; 2007 Mar; 195(5):615-7. PubMed ID: 17262699
    [No Abstract]   [Full Text] [Related]  

  • 2. International consensus guidelines on the management of cytomegalovirus in solid organ transplantation.
    Kotton CN; Kumar D; Caliendo AM; Asberg A; Chou S; Snydman DR; Allen U; Humar A;
    Transplantation; 2010 Apr; 89(7):779-95. PubMed ID: 20224515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of outcomes related to cytomegalovirus in organ transplant recipients.
    Singh N
    Transplantation; 2006 Jul; 82(1):15-6. PubMed ID: 16861935
    [No Abstract]   [Full Text] [Related]  

  • 4. Immune-based monitoring for cytomegalovirus infection in solid organ transplantation: is it ready for clinical primetime?
    Melendez D; Razonable RR
    Expert Rev Clin Immunol; 2014 Sep; 10(9):1213-27. PubMed ID: 25081073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinically-based determination of safe DNAemia cutoff levels for preemptive therapy or human cytomegalovirus infections in solid organ and hematopoietic stem cell transplant recipients.
    Lilleri D; Baldanti F; Gatti M; Rovida F; Dossena L; De Grazia S; Torsellini M; Gerna G
    J Med Virol; 2004 Jul; 73(3):412-8. PubMed ID: 15170637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytomegalovirus in solid organ transplantation.
    Razonable RR; Humar A;
    Am J Transplant; 2013 Mar; 13 Suppl 4():93-106. PubMed ID: 23465003
    [No Abstract]   [Full Text] [Related]  

  • 7. Defining the risks for cytomegalovirus infection and disease after solid organ transplantation.
    Stratta RJ; Pietrangeli C; Baillie GM
    Pharmacotherapy; 2010 Feb; 30(2):144-57. PubMed ID: 20099989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of cytomegalovirus infection and disease after solid-organ transplantation.
    van der Bij W; Speich R
    Clin Infect Dis; 2001 Jul; 33 Suppl 1():S32-7. PubMed ID: 11389520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral load, CMV-specific T-cell immune response and cytomegalovirus disease in solid organ transplant recipients at higher risk for cytomegalovirus infection during preemptive therapy.
    Martín-Gandul C; Pérez-Romero P; Blanco-Lobo P; Benmarzouk-Hidalgo OJ; Sánchez M; Gentil MA; Bernal C; Sobrino JM; Rodríguez-Hernández MJ; Cordero E;
    Transpl Int; 2014 Oct; 27(10):1060-8. PubMed ID: 24964364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unraveling the biologic basis of late-onset cytomegalovirus disease in high-risk organ transplant recipients.
    Singh N
    Transplantation; 2011 Apr; 91(8):825-6. PubMed ID: 21372754
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical aspects and management of cytomegalovirus infection.
    Sissons JG; Carmichael AJ
    J Infect; 2002 Feb; 44(2):78-83. PubMed ID: 12076065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cytomegalovirus infection in adults. Must it be treated?].
    Castón JJ; Torre-Cisneros J
    Med Clin (Barc); 2016 Oct; 147(8):345-347. PubMed ID: 27450161
    [No Abstract]   [Full Text] [Related]  

  • 13. The case for cytomegalovirus prophylaxis in solid organ transplantation.
    Snydman DR
    Rev Med Virol; 2006; 16(5):289-95. PubMed ID: 16888821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of cytomegalovirus disease in recipients of solid-organ transplants.
    Paya CV
    Clin Infect Dis; 2001 Feb; 32(4):596-603. PubMed ID: 11181123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late-onset cytomegalovirus disease as a significant complication in solid organ transplant recipients receiving antiviral prophylaxis: a call to heed the mounting evidence.
    Singh N
    Clin Infect Dis; 2005 Mar; 40(5):704-8. PubMed ID: 15714416
    [No Abstract]   [Full Text] [Related]  

  • 16. Cytomegalovirus: the taming of the beast?
    Goodrich J; Khardori N
    Lancet; 1997 Dec; 350(9093):1718-9. PubMed ID: 9413457
    [No Abstract]   [Full Text] [Related]  

  • 17. Preemptive versus prophylactic approaches in the management of cytomegalovirus disease in solid organ transplant recipients: what we know and what we do not know.
    Meylan PR; Pascual M
    Clin Infect Dis; 2006 Oct; 43(7):881-3. PubMed ID: 16941369
    [No Abstract]   [Full Text] [Related]  

  • 18. [Recommendations for the diagnosis and therapy of cytomegalovirus infection after stem-cell transplantation. The Research Alliance on the Complications of Organ Transplantation due to Herpes Viruses].
    Einsele H; Herbart H; Bock T; Müller C; Fleckenstein B; Mach M; Stamminger T; Jahn G; Sinzger C; Koszinowski U; Meyer-König U; Mertens T; Plachter B; Reddehase MJ; Schmidt CA
    Dtsch Med Wochenschr; 1999 Apr; 124(16):501-6. PubMed ID: 10341755
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunomonitoring for cytomegalovirus infection in kidney transplantation: Development and prospects].
    Kaminski H; Couzi L; Déchanet-Merville J; Merville P
    Nephrol Ther; 2015 Nov; 11(6):465-73. PubMed ID: 26206770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral treatment after solid organ transplantation.
    Caplin B; Sweny P; Burroughs A; Emery V; Griffiths P
    Lancet; 2005 Sep 3-9; 366(9488):806-7; author reply 807. PubMed ID: 16139651
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.